American Society of Hematology Announces 2017-2018 Physician-Scientist Career Development Award Recipients
(WASHINGTON, May 8, 2017) – The American Society of Hematology (ASH) has announced the latest round of medical students selected to receive the 2017-2018 ASH Physician-Scientist Career Development Award. This award program allows students attending accredited medical schools in the United States or Canada to gain experience in hematology research under the mentorship of an ASH member.
Two students have been selected to receive the ASH Physician-Scientist Career Development Award. Mara Rosenberg, of the Oregon Health & Science University in Portland, Oregon, will spend the year studying next generation sequencing-based minimal residual disease detection assays for patients with leukemia. Max Brodsky, of Drexel University College of Medicine in Philadelphia, Pennsylvania, will explore mechanisms of ruxolitinib resistance in JAK2/ASXL1 double-mutant myeloproliferative neoplasms.
From July 1, 2017, through June 30, 2018, program participants will immerse themselves in hematology studies, spending more than 80 percent of their time conducting laboratory, translational, or clinical research. They will receive a total award amount of $42,000, which will help cover their supplies, insurance, educational expenses, salary, and meeting attendance.
“Mentorship and training of the next generation of hematologists is of utmost importance to ASH,” said ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. “Mara and Max are two talented medical students who show dedication and enthusiasm for hematology research, and ASH is thrilled to foster their continued growth and guide them toward successful research careers.”
The American Society of Hematology (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925